Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome
This study is currently recruiting participants.
Verified August 2011 by University of Padova
Study NCT00742690
Information provided by University of Padova
First Received on August 26, 2008.
Last Updated on August 4, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
